• Home
  • Downloads
  • Contact Us
  • Site Map
  • Corporate Website

Crucell 2008
Combating Infectious Diseases
Annual Report and Form 20–F

Crucell logo
  • Overview
  • Our business
  • Our commitment to CSR
  • Management report
  • Financial statements
  • Other information
  • Print page

Management Report

  • Overview
    • 2008 Key Highlights
    • Crucell at a Glance
    • Crucell: A Global Perspective
    • Performance Highlights
      • Financials
      • Revenue and other operating income
      • Outlook for 2009
      • IFRS selected financial data
    • Message from our CEO
      • The Crucell Ambition
    • Management Committee
    • Report of the Supervisory Board
  • Our business
    • Our Products and Research & Development Pipeline
    • Products
    • Research & Development
      • Key pipeline developments
      • AdVac® technology and AdVac®-based vaccines
      • Antibodies
    • Technologies
  • Our commitment to CSR
    • What Corporate Social Responsibility means to us
    • What we do
    • A CSR dilemma
    • Crucell on its mission to combat infectious diseases
    • Who we work with
    • An example: Warm response to cold chain training
    • How we do business
    • A partnership with customers illustrated
    • Crucell's PER.C6® technology
    • How we see our responsibility
    • Crucell works in an environment that requires highly skilled employees
    • Innovative safety approach
    • Beyond legislation for safety
    • Environmental impact
    • An example: Combining vaccines for a diversity of benefits
    • Energy & water consumption
    • Economic aspects of our business
  • Management Report
  • Financial Statements
  • Other Information

© 2009 Crucell. All Rights Reserved

  • Disclaimer